₹19.4
▲ +1.1 +6.01%
17 Jul 2026
NSE Listed
Medistep Healthcare Ltd. (MEDISTEP)
Volume: 6,000Avg Vol 1W: 3,000Avg Vol 1M: 5,10052W Range:₹16.5₹53
Key Ratios
Checked 6h agoMarket Cap₹26 Cr
Current Price₹19.4
Previous Close₹18.3
High / Low (52w)₹53 / ₹16.5
Volume6,000
Avg Vol (1W)3,000
Avg Vol (1M)5,100
Stock P/E4.35
Book Value₹26.62
Dividend Yield0%
ROE15.82%
ROA0%
Revenue (TTM)₹50 Cr
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹4.21
P/B0.69
Debt / Equity0.03
50 DMA₹19.77
200 DMA₹24.83
Day change+6.01%
Price Chart
₹19.4▼ 61.47% · 1Y
2025-08-182026-07-16
20-day avg volume: 5K shares
Pros
- Healthy return on equity of 15.8%.
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 36% YoY.
Quarterly Results
| Metric | Jun 2024 |
|---|---|
| Revenue | ₹11 Cr |
| EBITDA | ₹1 Cr |
| Net Profit | ₹1 Cr |
| EPS | — |
Profit & Loss (Annual)
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Revenue | ₹32 Cr | ₹50 Cr |
| EBITDA | ₹4 Cr | ₹6 Cr |
| Net Profit | ₹3 Cr | ₹4 Cr |
| EPS | 19.96 | 4.01 |
Balance Sheet
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Total Assets | ₹15 Cr | ₹23 Cr |
| Total Liabilities | ₹3 Cr | ₹6 Cr |
| Equity | ₹12 Cr | ₹17 Cr |
| Total Debt | — | — |
Cash Flow
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Operating | ₹-7 Cr | ₹0 Cr |
| Investing | ₹0 Cr | ₹0 Cr |
| Financing | ₹7 Cr | ₹1 Cr |
| Free Cash Flow | ₹-7 Cr | ₹0 Cr |
Shareholding
Promoter 68.96% Institutions 0% Public 31.04%
Efficiency & Working Capital
ROCE19.2%
Interest Coverage139.3
Dividend Payout—
Debtor Days148 d
Inventory Days8 d
Payable Days18 d
Cash Conversion Cycle138 d
Working Capital Days156 d
Shareholding Details
As of 2026-03-31
Promoter69%
FII0%
DII0%
Institutions0%
Public31%
Promoter Pledge0%
No. of Shareholders514
Shareholding Pattern
Quarterly — figures in %. Latest 5 quarters.
| Period | Dec 2024 | Aug 2025 | Aug 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoters | 93.6% | 69% | 69% | 69% | 69% |
| FIIs | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% |
| Public | 6.4% | 31% | 31% | 31% | 31% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 8 | 525 | 525 | 578 | 514 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Prajapati Hetalben Shankarlal | Shareholding of Promoter and Promoter Group | 50.1% | 71,16,400 |
| Girdharilal Prajapat | Shareholding of Promoter and Promoter Group | 9.9% | 14,11,800 |
| Vipul Gobarbhai Dabhi | Shareholding of Promoter and Promoter Group | 8.9% | 12,69,880 |
| Nitin Singh Bhati | Public Shareholding | 4.7% | 6,66,666 |
| Vijith Narayanan Menon | Public Shareholding | 2.6% | 3,69,000 |
| Tirulekha Biosciences Private Limited | Public Shareholding | 1.9% | 2,76,000 |
| Babitha Menon | Public Shareholding | 1.8% | 2,55,000 |
| Dharmishthaben Vipulbhai Dabhi | Shareholding of Promoter and Promoter Group | 0% | 200 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Prajapati Hetalben Shankarlal | 0 | 0% | 2026-03-31 |
| Girdharilal Prajapat | 0 | 0% | 2026-03-31 |
| Vipul Gobarbhai Dabhi | 0 | 0% | 2026-03-31 |
| Dharmishthaben Vipulbhai Dabhi | 0 | 0% | 2026-03-31 |
| Nitin Singh Bhati | 0 | 0% | 2026-03-31 |
| Vijith Narayanan Menon | 0 | 0% | 2026-03-31 |
| Babitha Menon | 0 | 0% | 2026-03-31 |
| Tirulekha Biosciences Private Limited | 0 | 0% | 2026-03-31 |
| Prajapati Hetalben Shankarlal | 0 | 0% | 2025-09-30 |
| Girdharilal Prajapat | 0 | 0% | 2025-09-30 |
| Vipul Gobarbhai Dabhi | 0 | 0% | 2025-09-30 |
| Dharmishthaben Vipulbhai Dabhi | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Girdhari Lal Prajapat | Managing Director | 2025 |
| Vipul Gobarbhai Dabhi | Executive Director | 2025 |
| Hetalben Girdharilal Prajapati | Non Executive Director | 2025 |
| Anandbhai Jitendrabhai Khoda | Independent Non Exe. Director | 2025 |
| Kapilbhai Raysinhbhai Dodiya | Independent Non Exe. Director | 2025 |
| Sashikala Bhutra | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing segment | ₹13 Cr | 26.5% |
| Trading | ₹36 Cr | 73.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 15 | 10 | 10 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 6 | 6 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Company Information
🌐 www.medistephc.com ↗
📍 05 S.#-245/B Plot-19 T.P.S.56, Free Way Trade Center Narol, Ahmedabad, Gujarat, 382405
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search